Clinical trials
Terminated Phase 1 Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Samus Therapeutics, Inc. | 2 |
| AbbVie | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| City of Hope Medical Center | 1 |
| Exelixis | 1 |
| Gilead Sciences | 1 |
| John Mascarenhas | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 19 |
| Leukemia, Myeloid, Acute | 8 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Myelodysplastic Syndromes | 7 |
| Myeloproliferative Disorders | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Polycythemia Vera | 6 |
| Hodgkin Disease | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.